| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 149.950 | 141.325 | - | 164.878 | 166.386 | 185.321 | 196.430 | 219.155 | 207.892 | 199.300 |
| Total Income - EUR | 149.951 | 141.330 | - | 164.878 | 166.411 | 185.321 | 196.431 | 219.157 | 207.893 | 199.301 |
| Total Expenses - EUR | 136.717 | 130.353 | - | 146.457 | 145.882 | 158.845 | 175.414 | 185.577 | 201.769 | 227.322 |
| Gross Profit/Loss - EUR | 13.234 | 10.977 | - | 18.422 | 20.528 | 26.476 | 21.017 | 33.579 | 6.124 | -28.020 |
| Net Profit/Loss - EUR | 11.116 | 9.250 | - | 16.774 | 18.864 | 24.936 | 19.092 | 31.388 | 4.045 | -28.020 |
| Employees | 0 | 0 | - | 0 | 0 | 0 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Danira Medfarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | 0 | 0 | 467 | 0 | 26.180 | 45.855 |
| Current Assets | 30.598 | 52.528 | - | 93.151 | 112.845 | 136.111 | 130.032 | 178.370 | 150.282 | 95.610 |
| Inventories | 10.738 | 10.465 | - | 12.464 | 16.206 | 18.358 | 17.430 | 28.395 | 47.518 | 59.819 |
| Receivables | 19.861 | 4.623 | - | 18.977 | 14.713 | 20.428 | 22.977 | 32.300 | 91.884 | 23.097 |
| Cash | 0 | 37.440 | - | 61.709 | 81.926 | 97.325 | 89.625 | 117.676 | 10.879 | 12.693 |
| Shareholders Funds | 13.437 | 33.561 | - | 52.619 | 70.464 | 88.904 | 92.869 | 114.406 | 111.512 | 53.627 |
| Social Capital | 225 | 223 | - | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 17.162 | 18.967 | - | 40.531 | 42.381 | 47.207 | 37.630 | 63.964 | 64.949 | 87.838 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Danira Medfarm Srl